Axsome Therapeutics Receives New U.S. Patent Covering AXS-02 for the Treatment of Complex Regional Pain Syndrome; Provides Patent Protection for AXS-02 into 2033 and Covers Uses of Oral Zoledronic Acid for Complex Regional Pain Syndrome
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
|AXSM||Community voting in process|
Slingshot Insights Explained
Don’t see a project related to the catalyst you care about?